Market Overview:
The global tissue diagnostics market size reached US$ 5.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.5 Billion by 2028, exhibiting a growth rate (CAGR) of 6.8% during 2023-2028.
Tissue diagnostics include the analysis and testing of specific tissue samples by capturing the biological context of diseases. They are used to detect certain medical conditions like cancer and inflammatory disorders and reveal the exact type and degree of malignancy which assists in identifying potential causes and treatment options. Tissue diagnostics are highly accurate, inexpensive and can be carried out by different techniques like core and open biopsy. Nowadays, advanced technologies like immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and special staining are also being employed for performing these diagnoses.
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Owing to the declining fertility rates and increased life expectancy, the overall share of the geriatric population is currently experiencing steady growth worldwide. This is a crucial factor contributing to the market growth as older adults are more susceptible to chronic diseases and thus require frequent check-ups and diagnoses. Apart from this, altering food patterns, rising alcohol consumption and reduced physical activities among individuals have led to a rise in the incidences of several lifestyle diseases. In addition to this, the rising prevalence of various types of cancers among all age groups has also led to a surge in demand for these diagnostic services.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global tissue diagnostics market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product type, technology, disease and end-user.
Breakup by Product Type:
Breakup by Technology:
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Immunohistochemistry
- In Situ Hybridization
- Digital Pathology and Workflow Management
- Special Staining
Breakup by Disease:
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer
- Others
Breakup by End-User:
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Others
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex, Cell Signaling Technology, etc
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2022 |
Historical Period |
2017-2022 |
Forecast Period |
2023-2028 |
Units |
US$ Billion |
Segment Coverage |
Product Type, Technology, Disease, End-User, Region |
Region Covered |
North America, Europe, Asia Pacific, Middle East and Africa, Latin America |
Companies Covered |
Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex and Cell Signaling Technology |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global tissue diagnostics market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global tissue diagnostics industry?
- What has been the impact of COVID-19 on the global tissue diagnostics industry?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the disease?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the global tissue diagnostics industry?
- What are the key driving factors and challenges in the global tissue diagnostics industry?
- What is the structure of the global tissue diagnostics industry and who are the key players?
- What is the degree of competition in the global tissue diagnostics industry?
- What are the profit margins in the global tissue diagnostics industry?